Zobrazeno 1 - 10
of 15
pro vyhledávání: '"María Gabriela Villamizar‐Sarmiento"'
Autor:
Daniela Carrillo, Natalie Edwards, David Arancibia‐Altamirano, Fabiola Otárola, Cynthia Villarroel, Catalina P Prieto, María Gabriela Villamizar‐Sarmiento, Daniela Sauma, Fernando Valenzuela, José Lattus, Felipe Oyarzun‐Ampuero, Verónica Palma
Publikováno v:
Bioengineering & Translational Medicine, Vol 8, Iss 2, Pp n/a-n/a (2023)
Abstract Psoriasis vulgaris is an inflammatory disease characterized by distinctive skin lesions and dysregulated angiogenesis. Recent research uses stem cell secretion products (CM); a set of bioactive factors with therapeutic properties that regula
Externí odkaz:
https://doaj.org/article/b033a867a95b48ae9283fb3343bc9c21
Autor:
María Gabriela Villamizar-Sarmiento, Ignacio Moreno-Villoslada, Samuel Martínez, Annesi Giacaman, Victor Miranda, Alejandra Vidal, Sandra L. Orellana, Miguel Concha, Francisca Pavicic, Judit G. Lisoni, Lisette Leyton, Felipe A. Oyarzun-Ampuero
Publikováno v:
Nanomaterials, Vol 9, Iss 7, p 944 (2019)
We report on the design, development, characterization, and a preliminary cellular evaluation of a novel solid material. This material is composed of low-molecular-weight hyaluronic acid (LMWHA) and polyarginine (PArg), which generate aqueous ionic n
Externí odkaz:
https://doaj.org/article/f6ac531a1d4d4e15b236df92b3bd04a4
Autor:
Anita Umerska, Caroline Gaucher, Felipe Oyarzun-Ampuero, Isabelle Fries-Raeth, Florence Colin, María Gabriela Villamizar-Sarmiento, Philippe Maincent, Anne Sapin-Minet
Publikováno v:
Antioxidants, Vol 7, Iss 4, p 46 (2018)
Despite the promising biological and antioxidant properties of curcumin, its medical applications are limited due to poor solubility in water and low bioavailability. Polymeric nanoparticles (NPs) adapted to oral delivery may overcome these drawbacks
Externí odkaz:
https://doaj.org/article/4b143848f618403eb495564ea4e39440
Autor:
null Daniela Carrillo, null Natalie Edwards, null David Arancibia‐Altamirano, null Fabiola Otárola, null Cynthia Villarroel, null Catalina P Prieto, null María Gabriela Villamizar‐Sarmiento, null Daniela Sauma, null Fernando Valenzuela, null José Lattus, null Felipe Oyarzun‐Ampuero, null Verónica Palma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3eff075fe6eed092311905ba12122bff
https://doi.org/10.1002/btm2.10443/v2/response1
https://doi.org/10.1002/btm2.10443/v2/response1
Autor:
Valeria Villanueva, Fabrizzio Valdés, Rommy N. Zúñiga, María Gabriela Villamizar-Sarmiento, Eduardo Soto-Bustamante, Patricio Romero-Hasler, Ana Luisa Riveros, Jose Tapia, Judit Lisoni, Felipe Oyarzun-Ampuero, Carolina Valenzuela
Publikováno v:
Food Hydrocolloids. 142:108813
Autor:
Ignacio Moreno-Villoslada, Juan Guerrero, María Gabriela Villamizar-Sarmiento, Felipe A. Oyarzun-Ampuero
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 166:19-29
The efficient association and controlled release of hydrophilic and aromatic low molecular-weight drugs (HALMD) still remains a challenge due to their relatively weak interactions with excipients and strong affinity to water. Considering that a wide
Autor:
Carolina Valenzuela, Héctor Hidalgo, María Gabriela Villamizar-Sarmiento, Leonardo Sáenz, Sonia Vidal, Constanza Avendaño, Lisette Lapierre, Miguel Guzmán
Publikováno v:
Polymers
Volume 13
Issue 19
Polymers, Vol 13, Iss 3426, p 3426 (2021)
Volume 13
Issue 19
Polymers, Vol 13, Iss 3426, p 3426 (2021)
The aim of this study was to develop and characterize Salmonellaenterica serovar Infantis (S. Infantis) cochleates protected by encapsulation technology as a potential vaccine and to determine its safety in pullets. Cochleates were encapsulated by tw
Autor:
Manuel Sánchez, María Gabriela Villamizar-Sarmiento, Iliak Harmsen, Fabrizzio Valdés, Valeria Villanueva, Ricardo Ceballos, Jurij Wacyk, Felipe Oyarzun-Ampuero, Carolina Valenzuela
Publikováno v:
LWT. 163:113597
Background: Chloroquine (CQ) is a drug commonly used to treat malaria. CQ has also gained interest for the treatment of other chronic diseases such as arthritis, lupus, cancer, diabetes, atherosclerosis, and dermatomyositis, among others. Since CQ is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87ab46d228255dd2b6a1cff13cbb9390
https://doi.org/10.21203/rs.3.rs-101145/v1
https://doi.org/10.21203/rs.3.rs-101145/v1
Autor:
María Paz Ocaranza, Andrea Ramírez-Sagredo, Mario Chiong, Ana Riveros, Javier O. Morales, María Gabriela Villamizar Sarmiento, Aldo Rojas, Jaime A. Riquelme, Yvo Flores, Marcelo J. Kogan, Fanny Guzmán, Francisco Morales-Zavala, Eyleen Araya, Julian Bejarano, Gina Sánchez, Sergio Lavandero
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 328
Angiotensin-(1-9), a component of the non-canonical renin-angiotensin system, has a short half-life in blood. This peptide has shown to prevent and/or attenuate hypertension and cardiovascular remodeling. A controlled release of angiotensin-(1-9) is